期刊文献+

克银Ⅰ号方对寻常型银屑病患者血清白细胞介素-2、白细胞介素-2受体及肿瘤坏死因子-α的影响 被引量:5

Effects of KeyinⅠRecipe on IL-2、IL-2R and TNF-α in serum of psoriasis
在线阅读 下载PDF
导出
摘要 目的观察克银Ⅰ号方对寻常型银屑病患者血清白细胞介素-2(IL-2)、白细胞介素-2受体(IL-2R)及肿瘤坏死因子-α(TNF-α)的影响。方法将80例寻常型银屑病患者随机分为2组,治疗组40例应用克银Ⅰ号方治疗,对照组40例应用阿维A胶囊治疗。2组均30 d为1个疗程,治疗3个疗程后进行疗效评定。并选取30例健康体检者对照。结果治疗组总有效率85.0%,对照组总有效率87.5%,2组总有效率比较差异无统计学意义(P﹥0.05)。2组治疗前IL-2水平均低于健康体检者(P<0.01),IL-2R及TNF-α水平均高于健康体检者(P<0.01)。2组治疗后IL-2水平均较本组治疗前提高(P<0.01),IL-2R及TNF-α水平均较本组治疗前降低(P<0.01)。2组治疗后IL-2、IL-2R及TNF-α水平比较差异均无统计学意义(P﹥0.05)。结论克银Ⅰ号方可以通过改善银屑病患者血清IL-2、IL-2R及TNF-α发挥治疗作用,且无明显不良反应。 Objective To observe the effect of Keyin I Recipe on IL- 2,IL- 2R and TNF -α in psoriasis and its mechanism. Methods 80 cases of psoriasis were randomized into two groups. Keyin I Recipe .treatment group (treatment group) received Keyin I Recipe and Acitretin Capsules treatment group (control group) received Acitretin Capsules. The course was 30 days in two groups. 30 healthy volunteers were selected as normal control group. The levels of IL - 2, IL - 2R and TNF - α in serum before and after treatment were measured. The effect was evaluated after three courses. Results As compared with normal control group the level of IL -2 was lower, and the levels of IL - 2R and TNF - α in patients were higher ( P 〈 0.01 ). the level of IL - 2 after treatment was signifi- cantly increased as compared with that before treatment in two groups ( P 〈 0.05 ). And the levels of IL - 2R and TNF - α were significantly decreased ( P 〈 0. 01 ). There was no significant difference between two groups on the levels of IL - 2, IL - 2R and TNF - α after treatment ( P 〉 0.05 ). The total effective rate in treatment group was 85.0% , and 87.5% in control group. There was no obvious difference between two groups ( P 〉 0.05 ). Conclusion Keyin I Recipe is effective in adjusting the levels of IL - 2, IL - 2R and TNF - α in serum of patients with psoriasis.
出处 《河北中医》 2011年第11期1617-1619,共3页 Hebei Journal of Traditional Chinese Medicine
基金 河北省科学技术研究与发展计划项目(编号:09276418D-22)
关键词 银屑病 中药疗法 白细胞介素2 受体 白细胞介素2 肿瘤坏死因子Α Psoriasis Chinese Medicine Therapy 1L - 2 Receptor TNF - α
作者简介 作者简介:马学伟(1968-),女,副主任医师,学士。从事中西医结合治疗皮肤病临床工作。
  • 相关文献

参考文献7

二级参考文献22

  • 1张国安.肿瘤坏死因子的研究进展[J].中国实验临床免疫学杂志,1989,1(5):43-45. 被引量:33
  • 2陈晓燕,朱迅.可溶性因子与肿瘤转移[J].国外医学(肿瘤学分册),1996,23(3):147-150. 被引量:4
  • 3张文南.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1998.270-275.
  • 4Marshall BJ. Helicobacter pylori [J ]. Am J Gastroenterol, 1994, 89(8): S116-128.
  • 5Giraudo E, primo 1., Audero E, et al. Tumor necrosis factor-a regulates expression of vascular endothelial growth factor receptor -2 and of its coreceptor neuropilin-1 human vascular endothelial Cells[J]. J Biol Chem, 1998, 272(34) : 22128 - 22135.
  • 6Cordingley FT, Bianchi A, Hoffbrand AV, et al. Tumour necrosis factor as anautocrinc tumour growh factor for chronic B - cell nmligmancics[J]. Lancet, 1988, 1(8592) : 969- 971.
  • 7Strieter RM, Chensue SW, Basha MA, et al. Human alevolar nmcrophage gene expression of interleukin-8 by tumomecrosis facter, alipolysaccharide and interleukin-1 [J]. Am J Respir Cell Mol Biol, 1990, 2(4): 321-326.
  • 8Robin LA, Neson DL. The Soluble interleukin - 2 receptor biology,function, and clinical application [J]. Ann Inter Med, 1990, 113 (8) :619 - 627.
  • 9孙卫民 王惠琴.细胞因子研究方法学[M].人民卫生出版社,2000.596-597.
  • 10Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of infliximab monotherapy for plaque - type psoriasis : a randomised trial[J]. Lancet, 2001,357(9271 ) :1842-1847.

共引文献44

同被引文献90

  • 1李钰蛟,佟琳,唐丹丽,张华敏.靶标网络与中医药研究[J].中国中医药图书情报杂志,2014,38(3):54-56. 被引量:4
  • 2印利华,常洪,张永红.清热凉血汤治疗寻常性银屑病162例疗效观察[J].中国医学文摘(皮肤科学),2010,27(5):282-283. 被引量:4
  • 3王珏,周志愉,易剑峰,何颖辉,贾红伟,吕爱平.雷公藤免疫调节作用研究进展[J].中国中医基础医学杂志,2006,12(3):230-232. 被引量:23
  • 4Nickoloff BJ. Cracking the cytokine code in psoria- sis[J].Nat Med, 2007.13(3):242-244.
  • 5Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and the- rapy of psoriasis[J].Nature,2007,445 (7130):866-873.
  • 6Liu H,Liu ZH, Chen ZH,et al. Triptolide:a potent inhi- bitor of NF-κB in T-lymphocytes[J].hcta Pharmacol Sinica,2000,21(9):782-786.
  • 7Tak PP,Firestein GS. NF-xB:A key role in inflamma- tory diseases[J].J clin Invest,2001,107(1):7-11.
  • 8Lee Jang IK,Pharm D, Gibert J,et al. Nuclear factor kappa B:important transcription factor and thera- pentic target[J].J Clin'Pharmacol,1998,38(11):981- 993.
  • 9Christman JW,Lan Caster LH,Black Well TS,et al. Nu- clear factorxB:a piovtal role in the systemic infl- ammory response syndrome and new target for therapy [J].Intensive Care Med, 1998,24:1131-1138.
  • 10D'Acquisto F,May MJ,Ghosh S. Inhibition of nuclear factor kappa B (NF-B):an emerging theme in anti- inflammatory therapies[J].Mol Interv,2002,2(1):22- 35.

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部